Effect of CPAP Treatment in Women With Moderate-to-severe OSA.

NCT02047071 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 307

Last updated 2015-08-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether Continuous Positive Airways Pressure (CPAP) improves quality of life, cardiovascular (blood pressure) and metabolic profile (glucose and lipid metabolism) in females with moderate-to-severe Obstructive Sleep Apnea (OSA).

Conditions

Interventions

DEVICE

Continuous positive airways pressure

Optimal Continuous positive airways pressure treatment every night plus standard care for OSA consisting of hygienic-dietary advice and lifestyle counseling.

Sponsors & Collaborators

  • Fondo de Investigacion Sanitaria

    collaborator OTHER
  • Sociedad Española de Neumología y Cirugía Torácica

    collaborator OTHER
  • Francisco Campos-Rodriguez

    lead OTHER

Principal Investigators

  • Francisco Campos-Rodriguez, MD · Sociedad Española de Neumología y Cirugía Torácica

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02047071 on ClinicalTrials.gov